Federal Register Notice: FDA solicits comments on the collection of information contained in a guidance entitled Guidance for Industry on Submitting and Reviewing Complete Responses to Clinical Holds. The guidance describes how to submit a complete response if an investigational new drug application is placed on clinical hold by FDA. To view this notice, click here.
